![Animals | Free Full-Text | Effects of Multimodal Analgesic Protocol, with Buprenorphine and Meloxicam, on Mice Well-Being: A Dose Finding Study Animals | Free Full-Text | Effects of Multimodal Analgesic Protocol, with Buprenorphine and Meloxicam, on Mice Well-Being: A Dose Finding Study](https://www.mdpi.com/animals/animals-11-03420/article_deploy/html/images/animals-11-03420-g001.png)
Animals | Free Full-Text | Effects of Multimodal Analgesic Protocol, with Buprenorphine and Meloxicam, on Mice Well-Being: A Dose Finding Study
Buprenorphine analgesia in DOR, KOR, ORL-1, and triple opioid receptor... | Download Scientific Diagram
![Pharmacokinetic comparison of sustained-release and standard buprenorphine in mice. - Abstract - Europe PMC Pharmacokinetic comparison of sustained-release and standard buprenorphine in mice. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4113239/bin/jaalas2014000387f03.jpg)
Pharmacokinetic comparison of sustained-release and standard buprenorphine in mice. - Abstract - Europe PMC
![Buprenorphine Antinociception is Abolished, but Naloxone-Sensitive Reward is Retained, in μ-Opioid Receptor Knockout Mice | Neuropsychopharmacology Buprenorphine Antinociception is Abolished, but Naloxone-Sensitive Reward is Retained, in μ-Opioid Receptor Knockout Mice | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.npp.1300463/MediaObjects/41386_2004_Article_BF1300463_Fig1_HTML.gif)
Buprenorphine Antinociception is Abolished, but Naloxone-Sensitive Reward is Retained, in μ-Opioid Receptor Knockout Mice | Neuropsychopharmacology
![Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors | Journal of Neuroscience Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/23/32/10331/F7.large.jpg)
Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors | Journal of Neuroscience
![Buprenorphine fails to produce antinociception in mice lacking-opioid... | Download Scientific Diagram Buprenorphine fails to produce antinociception in mice lacking-opioid... | Download Scientific Diagram](https://www.researchgate.net/profile/Wendy_Walwyn/publication/9012194/figure/fig4/AS:668610410332184@1536420552607/Buprenorphine-fails-to-produce-antinociception-in-mice-lacking-opioid-receptors-Mice_Q640.jpg)
Buprenorphine fails to produce antinociception in mice lacking-opioid... | Download Scientific Diagram
![Administration of Tramadol or Buprenorphine via the drinking water for post-operative analgesia in a mouse-osteotomy model | Scientific Reports Administration of Tramadol or Buprenorphine via the drinking water for post-operative analgesia in a mouse-osteotomy model | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-47186-5/MediaObjects/41598_2019_47186_Fig1_HTML.png)
Administration of Tramadol or Buprenorphine via the drinking water for post-operative analgesia in a mouse-osteotomy model | Scientific Reports
![Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo | Neuropsychopharmacology Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41386-021-00976-w/MediaObjects/41386_2021_976_Fig1_HTML.png)
Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo | Neuropsychopharmacology
Weight (grms) kg mg Dose in ml 11 0.01 0.007 0.01 12 0.01 0.007 0.01 13 0.01 0.008 0.02 14 0.01 0.008 0.02 15 0.02 0.009 0.02 16
![Buprenorphine for pain relief in mice: repeated injections vs sustained-release depot formulation - P Jirkof, A Tourvieille, P Cinelli, M Arras, 2015 Buprenorphine for pain relief in mice: repeated injections vs sustained-release depot formulation - P Jirkof, A Tourvieille, P Cinelli, M Arras, 2015](https://journals.sagepub.com/cms/10.1177/0023677214562849/asset/images/large/10.1177_0023677214562849-fig7.jpeg)